200 patients with triple negative breast cancer will be followed up. Peripheral venous blood was collected every 3 to 6 months. Change regularity of breast cancer-specific immune inflammation-related protein complexes in blood at different follow-up time points will be studied. The relationship between disease-specific protein complexes and pathological state of patients will be analyzed.
Age
36–60
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Female
Postoperative pathology confirmed invasive breast cancer after surgery for breast lump
Breast cancer-related chemotherapy and radiotherapy completed
triple negative breast cancer patients
age ≤ 60 years old
You may not be if
Male
Aged above 60
Breast Carcinoma in situ
Women in pregnancy or breastfeeding
Suffering from other malignant tumors
Non-compliant patient
Clareo Health | Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients
